AAA November 2014

Curetis extends series B round to $18m

Germany-based molecular diagnostics company Curetis has extended its series B round to €27m ($33.7m) after securing funding from drugs company Roche and molecular biology specialist Qiagen. The second tranche totalled approximately $18.1m, $8.7m of which was provided by Qiagen and healthcare insurer Achmea, which participated via its LSP Health Economics Fund, formed with Life Sciences… Continue reading Curetis extends series B round to $18m

Weekly corporate venturing deal net: 24-28 November 2014

US-based advanced hearing aid developer iHear Medical expanded a series C round backed by office equipment maker Brother Industries and insurance firm Ameritas Holding Company to $5m on Monday. The first tranche of the round was led by venture capital firm Lighthouse Capital, and it follows a $1.8m round in 2012. The company’s earlier backers… Continue reading Weekly corporate venturing deal net: 24-28 November 2014